Fig. 2From: Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose StudyNumber of patients with different types of GLDs at baseline or first follow-up. Percentage of each group was calculated only among 352 patients who had been on GLDs at baseline or first follow-up, considering that for 8 patients, type of GLDs that they had used was missed. N number, GLD glucose lowering drugBack to article page